These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17921984)

  • 1. The FDA animal efficacy rule and biodefense.
    Gronvall GK; Trent D; Borio L; Brey R; Nagao L;
    Nat Biotechnol; 2007 Oct; 25(10):1084-7. PubMed ID: 17921984
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Nov; 73(217):66293-410. PubMed ID: 19112701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA and the tort system: postmarketing surveillance, compensation, and the role of litigation.
    Struve CT
    Yale J Health Policy Law Ethics; 2005; 5(2):587-669. PubMed ID: 16052895
    [No Abstract]   [Full Text] [Related]  

  • 7. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandatory post marketing studies.
    Somberg J
    Am J Ther; 2007; 14(4):321. PubMed ID: 17667203
    [No Abstract]   [Full Text] [Related]  

  • 9. New law gives FDA more influence to monitor drug safety.
    Wadman M
    Nat Med; 2007 Nov; 13(11):1269. PubMed ID: 17987008
    [No Abstract]   [Full Text] [Related]  

  • 10. US Senate passes FDA Revitalization Act.
    Guthrie P
    CMAJ; 2007 Jul; 177(1):23. PubMed ID: 17606930
    [No Abstract]   [Full Text] [Related]  

  • 11. Blowing the whistle at the FDA.
    Simons J
    Fortune; 2005 Jan; 151(2):32. PubMed ID: 15693304
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA asks LyphoMed to recall intravenous solution.
    Wagner M
    Mod Healthc; 1988 Jul; 18(31):5. PubMed ID: 10288204
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflict between FDA and medicine inevitable.
    Wholey MH; Haller JD
    Diagn Imaging (San Franc); 1995 Oct; 17(10):41-8, 87. PubMed ID: 10159849
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 15. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
    DerGurahian J
    Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
    [No Abstract]   [Full Text] [Related]  

  • 16. Administrative detention of food for human or animal consumption under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(108):31659-705. PubMed ID: 15181899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL; Hanson A; Guglielmetti TM; Levy K
    Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy currents. FDA addresses backlog of generic medication applications.
    Consult Pharm; 2006 May; 21(5):419-21. PubMed ID: 16929569
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA warns of stroke risk associated with phenylpropanolamine; cold remedies and drugs removed from store shelves.
    SoRelle R
    Circulation; 2000 Nov; 102(21):E9041-3. PubMed ID: 11185472
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA proposes tightening post-market oversight of medical devices.
    Roehr B
    BMJ; 2012 Sep; 345():e6140. PubMed ID: 22968864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.